EDGAR Filing Documents for 0001201935-10-000004

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001201935-10-000004

Filing Date

2010-01-19

Accepted

2010-01-19 14:55:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		memo424b3xtlbio.txt	424B3	1800
2		memoexhibitaxtlbio.txt	EX-1	47971
	Complete submission text file	0001201935-10-000004.txt		51131

Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989

Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 424B3 | Act: 33 | File No.: 333-147677 | Film No.: 10533072
SIC: 2834 Pharmaceutical Preparations